首页> 外文期刊>International archives of allergy and immunology >Asthma: Hospitalization Trends and Predictors of In-Hospital Mortality and Hospitalization Costs in the USA (2001-2010)
【24h】

Asthma: Hospitalization Trends and Predictors of In-Hospital Mortality and Hospitalization Costs in the USA (2001-2010)

机译:哮喘:美国的住院趋势和医院内死亡率与住院费用的预测因素(2001-2010年)

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In the last decade, the proportion of people with asthma in the USA grew by nearly 15%, with 479,300 hospitalizations and 1.9 million emergency department visits in 2009 alone. The primary objective of our study was to evaluate in-hospital outcomes in patients admitted with asthma exacerbation in terms of mortality, length of stay (LOS) and hospitalization costs. Methods: We queried the HCUP's Nationwide Inpatient Sample (NIS) between 2001 and 2010 using the ICD9-CM diagnosis code 493 for asthma (n = 760,418 patients). The NIS represents 20% of all hospitals in the USA. Multivariate logistic regression analysis was used to evaluate predictors of in-hospital mortality. LOS and hospitalization costs were also analyzed. Results: The overall LOS was 3.9 days and as high as 8.3 days in patients requiring mechanical ventilation. LOS has decreased in recent years, though it continues to be higher than in 2001. The hospitalization cost increased steadily over the study period. The overall in-hospital mortality was 1% and as high as 9.8% in patients requiring mechanical ventilation. Multivariate predictors of longer LOS, higher hospitalization costs and in-hospital mortality included increasing age and hospitalizations during the winter months. Private insurance was predictive of lower hospitalization costs and LOS as well as lower in-hospital mortality. Conclusion: Asthma continues to account for significant in-hospital mortality and resource utilization, especially in mechanically ventilated patients. Age, admissions during winter months and the type of insurance are independent predictors of in-hospital outcomes. (C) 2015 S. Karger AG, Basel
机译:背景:在过去的十年中,仅在2009年,美国哮喘患者的比例就增长了近15%,共住院治疗479,300例,急诊就诊190万人次。我们研究的主要目的是根据死亡率,住院时间和住院费用评估哮喘加重患者的住院结局。方法:我们使用ICD9-CM诊断代码493(哮喘患者760,418名)在2001年至2010年间查询了HCUP的全国住院患者样本(NIS)。 NIS占美国所有医院的20%。多元逻辑回归分析用于评估院内死亡率的预测因子。还分析了LOS和住院费用。结果:需要机械通气的患者的总LOS为3.9天,最高为8.3天。 LOS在近几年有所下降,尽管仍高于2001年。在研究期间,住院费用稳步上升。总体机械死亡率为1%,而需要机械通气的患者则高达9.8%。 LOS较长,住院费用增加和医院内死亡的多因素预测包括冬季期间年龄的增加和住院的增加。私人保险预示着较低的住院费用和LOS,以及较低的院内死亡率。结论:哮喘仍是造成院内死亡率和资源占用的重要原因,特别是在机械通气患者中。年龄,冬季入院率和保险类型是医院预后的独立预测因子。 (C)2015 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号